Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age

Документальный обзор ASEM

Official National Advisory Committee on Immunization document (2022) on “Archived 46: Summary of NACI statement of October 21, 2022: Recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years of age”. Summary of NACI recommendations on the use of Pfizer-BioNTech Comirnaty (3 mcg) COVID-19 vaccine in children 6 months to 4 years, including summary of evidence, clinical trial and safety data, authorized preparations and schedule.

Это краткое содержание помогает найти нужный документ. В отношении клинических рекомендаций всегда сверяйтесь с официальной версией и датой её обновления.